In breast, C/EBPβ most likely contributes to tumorigenesis through significant elevations in the LIP∶LAP ratio, mostly observed in ER-negative, highly proliferative and metastatic mammary tumours, usually associated with a poor patient prognosis [8]. This evidence concerns the gene CEBPB and breast cancer.